Usama Mahmood

The University of Texas MD Anderson Cancer Center

Papers

1

Total Citations

27

H-Index

1

About

Dr. Usama Mahmood is a leading urologic oncologist whose research centers on optimizing treatment outcomes and quality of life for men with prostate cancer. His most influential work directly compares the functional and quality-of-life impacts of two major treatment modalities: brachytherapy and robot-assisted radical prostatectomy. In his landmark 2017 prospective cohort study, Dr. Mahmood provided critical, patient-centered data that helps men make informed decisions about their care, a study that has garnered 27 citations for its practical clinical value. By meticulously analyzing post-treatment outcomes, he has advanced the understanding of how nerve-sparing surgical techniques and radiation therapies affect patients' daily lives. Dr. Mahmood’s research is distinguished by its focus on patient-reported outcomes, bridging the gap between clinical efficacy and real-world well-being. His contributions are essential for clinicians counseling patients on treatment trade-offs, ensuring that quality of life remains a central consideration in prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Quality of life after brachytherapy or bilateral nerve‐sparing robot‐assisted radical prostatectomy for prostate cancer: a prospective cohort
27 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago